Verification of drug license & valid prescription is strongly advised for the users before dealing in medicines

500Mg Natclovir Injection

₹ 1,563/Box

Strength500 mg
FormInjection
CompostionGanciclovir (500mg)
Prescription/Non prescriptionPrescription
Country of OriginMade in India
AvailabilityIn Stock
Natclovir Injection is an antiviral medicine used to treat viral infections caused by cytomegalovirus (CMV) in immunocompromised people who have undergone an organ or bone marrow transplantation. It also reduces the risk of blindness in a serious eye infection caused by CMV, known as CMV retinitis.

Exports To: United States Of America | Canada | United Kingdom | Saudi Arabia | Australia

Find products similar to 500Mg Natclovir Injection

Find related categories

Shipping Information

PriceExcluding all taxes
Ships fromSurat
ShippingAs per delivery location

Product Image

500Mg Natclovir Injection-1500Mg Natclovir Injection-2

Interested in this product?Get Latest Price from the seller

About the Company

GST Registration Date
03-06-2021
Legal Status of Firm
Proprietorship
Nature of Business
Trader - Retailer
Number of Employees
Upto 10 People
Annual Turnover
40 L - 1.5 Cr
IndiaMART Member Since
Feb 2016
GST
24AVGPG5660B1Z0
Import Export Code (IEC)
AVGPG*****
Exports to
United States Of America | Canada | United Kingdom | Saudi Arabia | Australia

Established in the year of 2015, “Medihome Pharma” are Wholesaler , Trader, Supplier And Exporter of Pharmaceutical Tablets, Pharmaceutical Injections, Hair Loss Medicines,ED Medicines,Anti-cancer medicines, etc. We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers.

For our accomplishment story, we are grateful to our Mr. Rinkesh Thakarshibhai Goyani (CEO), whose continual backing and direction have been useful to us for attaining exponential development in the current market.